Illustrative image – not actual.Agila Specialities, a subsidiary of Strides Arcolab, has acquired a US health regulator approved facility in Tamil Nadu.
Agila has acquired sterile formulations facility situated at Hosur, Tamil Nadu from Star Drugs and Research Labs in a deal valued about Rs 125 crore. However, identity of the company has not been revealed. The acquisition is being funded from cash in hand and internal accruals. The facility manufactures a wide range of injectable formats. Its liquid vials unit with a capacity of 97 million units has recently been approved by the US Food and Drug Administration (USFDA).
